Multiple mechanisms of serotonergic signal transduction
- PMID: 2441225
- DOI: 10.1016/0024-3205(87)90621-7
Multiple mechanisms of serotonergic signal transduction
Abstract
In this article we review serotonergic signal transduction mechanisms in the central and peripheral nervous systems and in a variety of target organs. The various classes of pharmacologically defined serotonergic receptors are coupled to three major effector systems: (1) adenylate cyclase; (2) phospholipase C mediated phosphoinositide (PI) hydrolysis and (3) ion channels (K+ and Ca++). Long term occupancy of serotonergic receptors also appears to induce alterations in mRNA and protein synthesis. For all three types of signal transduction there is evidence accumulating which suggests the involvement of guanine nucleotide regulatory proteins. Recent findings suggest that the distinct types of pharmacologically defined serotonergic receptors (5HT1A, 5HT1B, 5HT1c, 5HT2) may be coupled to one or more signal transduction systems. Thus, 5HT1 receptors may both activate and inhibit adenylate cyclase and increase K+-ion conductance in the hippocampus. 5HT2 receptors which activate PI hydrolysis in the brain, both open voltage-gated calcium channels and activate PI metabolism in certain smooth muscle preparations. Thus, each class of serotonergic receptor may be linked to one or more distinct biochemical transduction mechanisms. The possibility is raised that selective agonists and antagonists might be developed which have specific effects on a particular receptor-linked effector system.
Similar articles
-
Pharmacology of serotonin as related to anesthesia.J Clin Anesth. 1996 Aug;8(5):402-25. doi: 10.1016/0952-8180(96)00093-1. J Clin Anesth. 1996. PMID: 8832453 Review.
-
Central serotonin receptors: effector systems, physiological roles and regulation.Psychopharmacology (Berl). 1987;92(3):267-77. doi: 10.1007/BF00210830. Psychopharmacology (Berl). 1987. PMID: 2819915
-
Receptors and phosphoinositide metabolism in the central nervous system.Biochem Pharmacol. 1986 Aug 1;35(15):2447-53. doi: 10.1016/0006-2952(86)90038-9. Biochem Pharmacol. 1986. PMID: 2427081 Review. No abstract available.
-
Inhibitors of serotonin synthesis and antagonists of serotonin 1A receptors inhibit T lymphocyte function in vitro and cell-mediated immunity in vivo.J Immunol. 1994 Jul 15;153(2):489-98. J Immunol. 1994. PMID: 8021490
-
Presynaptic serotonergic inhibition of GABAergic synaptic transmission in mechanically dissociated rat basolateral amygdala neurons.J Physiol. 1999 Jul 15;518 ( Pt 2)(Pt 2):525-38. doi: 10.1111/j.1469-7793.1999.0525p.x. J Physiol. 1999. PMID: 10381597 Free PMC article.
Cited by
-
New concepts in pharmacological efficacy at 7TM receptors: IUPHAR review 2.Br J Pharmacol. 2013 Feb;168(3):554-75. doi: 10.1111/j.1476-5381.2012.02223.x. Br J Pharmacol. 2013. PMID: 22994528 Free PMC article. Review.
-
Further characterization of the 5-HT receptor mediating vascular relaxation and elevation of cyclic AMP in porcine isolated vena cava.Br J Pharmacol. 1989 May;97(1):292-300. doi: 10.1111/j.1476-5381.1989.tb11953.x. Br J Pharmacol. 1989. PMID: 2541857 Free PMC article.
-
Biased Ligands at the Kappa Opioid Receptor: Fine-Tuning Receptor Pharmacology.Handb Exp Pharmacol. 2022;271:115-135. doi: 10.1007/164_2020_395. Handb Exp Pharmacol. 2022. PMID: 33140224 Review.
-
A single unified model for fitting simple to complex receptor response data.Sci Rep. 2020 Aug 7;10(1):13386. doi: 10.1038/s41598-020-70220-w. Sci Rep. 2020. PMID: 32770075 Free PMC article.
-
Drug Repurposing Is a New Opportunity for Developing Drugs against Neuropsychiatric Disorders.Schizophr Res Treatment. 2016;2016:6378137. doi: 10.1155/2016/6378137. Epub 2016 Mar 17. Schizophr Res Treatment. 2016. PMID: 27073698 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous